RecruitingNCT06889883

Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer

Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools

Sponsor

ADVANCED MARKER DISCOVERY S.L.

Enrollment

510 participants

Start Date

Jun 6, 2023

Study Type

OBSERVATIONAL

Conditions

Colorectal Carcinoma Advanced Adenomas (AA)

Summary

This is a prospective, multicenter, case-control study. The aim is to develop an optimized algorithm by combining the levels of molecular markers in plasma together with risk factors for developing colorectal cancer and clinical data of patients diagnosed with CRC or AA and healthy individuals.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study develops and validates a blood test for the early detection of colorectal cancer (cancer of the colon or rectum). Participants give a blood sample before having a colonoscopy or surgery, allowing researchers to see whether the blood test can accurately identify cancer. **You may be eligible if...** - You are 18 or older and can understand the participant information and sign consent - You are already scheduled to have a colonoscopy or surgical tumor removal (for colorectal cancer) **You may NOT be eligible if...** - You have had any type of cancer in the past 5 years - You have received chemotherapy or radiation therapy - You have only non-advanced polyps or other non-malignant bowel conditions (certain exclusions apply) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.